| HGNC Family | Pleckstrin homology domain containing (PLEKH), SH2 domain containing, Rho guanine nucleotide exchange factors (ARHGEF) |
| Name | vav 2 guanine nucleotide exchange factor |
| Description | VAV2 is the second member of the VAV guanine nucleotide exchange factor family of oncogenes. Unlike VAV1, which is expressed exclusively in hematopoietic cells, VAV2 transcripts were found in most tissues. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nVAV2 is a ubiquitously expressed guanine nucleotide exchange factor (GEF) for Rho family GTPases that plays a critical role in cytoskeletal remodeling. Early studies established that activated VAV2 promotes Rac1 activation, thereby enhancing integrin‐mediated cell adhesion, membrane ruffling, and lamellipodia formation. Its regulatory function is dependent on specific structural domains—including the pleckstrin homology (PH) and cysteine‐rich (CRD) regions—and is subject to Src‐dependent phosphorylation events that facilitate its recruitment to membrane protrusions and sites of active signal transduction (["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "]).\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nVAV2 also functions as an integral downstream effector in growth factor and immune receptor signaling pathways. It becomes tyrosine phosphorylated in response to oncogenic Src and receptor activation, thereby linking signals from epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR‐2), and the B‐cell receptor to Rac1 activation. This modulation is key for processes such as cell spreading, endothelial migration and vascular remodeling, as well as for coupling antigen receptor signals to gene activation (["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "9"}]}, {"type": "t", "text": "]).\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn cancer cells, VAV2 contributes to a more aggressive phenotype by orchestrating cytoskeletal reorganization that drives cell migration, invasion, and metastasis. It is required for the maturation of invasive structures such as invadopodia—through interactions with phosphorylated cortactin and regulators like p120‐catenin—and cooperates with its family members to sustain transcriptional programs linked to tumor growth and metastasis. These activities underline a central role for VAV2 in modulating Rho/Rac signaling pathways that control both cell motility and invasiveness in diverse tumor types (["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "15"}]}, {"type": "t", "text": "]).\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its canonical role in Rac1 activation and cytoskeletal dynamics, VAV2 exerts multiple functions in diverse physiological and pathological contexts. It has been implicated in neuronal development and neurite outgrowth, regulation of insulin secretion, and modulation of DNA repair pathways that contribute to radioresistance. VAV2 also influences ribosome biogenesis and smooth muscle cell migration—processes that are key to tissue remodeling in the vasculature and pathologies like patent ductus arteriosus. Moreover, VAV2’s activity is finely tuned by its interactions with lipid membranes, viral proteins, and adaptor molecules (for example, binding phosphorylated motifs in partners such as Arap3), and genetic studies have linked variants in VAV2 to human diseases such as glaucoma, multiple sclerosis, and cardiovascular dysfunction. Collectively, these findings underscore the multifaceted role of VAV2 in transducing signals from cell surface receptors to downstream effectors across a range of normal and disease states ([."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "P A Marignani, C L Carpenter "}, {"type": "b", "children": [{"type": "t", "text": "Vav2 is required for cell spreading."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200103134"}], "href": "https://doi.org/10.1083/jcb.200103134"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11448999"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11448999"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Michelle A Booden, Sharon L Campbell, Channing J Der "}, {"type": "b", "children": [{"type": "t", "text": "Critical but distinct roles for the pleckstrin homology and cysteine-rich domains as positive modulators of Vav2 signaling and transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.22.8.2487-2497.2002"}], "href": "https://doi.org/10.1128/MCB.22.8.2487-2497.2002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11909943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11909943"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "William T Arthur, Lawrence A Quilliam, Jonathan A Cooper "}, {"type": "b", "children": [{"type": "t", "text": "Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200404068"}], "href": "https://doi.org/10.1083/jcb.200404068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15479739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15479739"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jongyun Heo, Roopa Thapar, Sharon L Campbell "}, {"type": "b", "children": [{"type": "t", "text": "Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi047443q"}], "href": "https://doi.org/10.1021/bi047443q"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15850391"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15850391"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Joan-Marc Servitja, Maria Julia Marinissen, Akrit Sodhi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M302960200"}], "href": "https://doi.org/10.1074/jbc.M302960200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12810717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12810717"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Isabelle Foucault, Séverine Le Bras, Céline Charvet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2003-08-2965"}], "href": "https://doi.org/10.1182/blood-2003-08-2965"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15345594"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15345594"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Tiana A Garrett, Jaap D Van Buul, Keith Burridge "}, {"type": "b", "children": [{"type": "t", "text": "VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2007.05.027"}], "href": "https://doi.org/10.1016/j.yexcr.2007.05.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17686471"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17686471"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "S Thalappilly, P Soubeyran, J L Iovanna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VAV2 regulates epidermal growth factor receptor endocytosis and degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.1"}], "href": "https://doi.org/10.1038/onc.2010.1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20140013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20140013"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "L S Havel, E R Kline, A M Salgueiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.123"}], "href": "https://doi.org/10.1038/onc.2014.123"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24858039"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24858039"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Vyomesh Patel, Hans M Rosenfeldt, Ruth Lyons, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgm008"}], "href": "https://doi.org/10.1093/carcin/bgm008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17234718"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17234718"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Laura Barrio-Real, Marcelo G Kazanietz "}, {"type": "b", "children": [{"type": "t", "text": "Rho GEFs and cancer: linking gene expression and metastatic dissemination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.2003543"}], "href": "https://doi.org/10.1126/scisignal.2003543"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23033535"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23033535"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Carmen Citterio, Mauricio Menacho-Márquez, Ramón García-Escudero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.2002962"}], "href": "https://doi.org/10.1126/scisignal.2002962"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23033540"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23033540"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Gabriela Valls, Montserrat Codina, Rachel K Miller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upon Wnt stimulation, Rac1 activation requires Rac1 and Vav2 binding to p120-catenin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.101030"}], "href": "https://doi.org/10.1242/jcs.101030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22946057"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22946057"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Chien-Yu Cho, Kuo-Ting Lee, Wei-Ching Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7542"}], "href": "https://doi.org/10.18632/oncotarget.7542"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26910843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26910843"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Brian J Rosenberg, Hava Gil-Henn, Christopher C Mader, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.E16-12-0885"}], "href": "https://doi.org/10.1091/mbc.E16-12-0885"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28356423"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28356423"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Kirsten Holthusen, Ana M Gonzalez, Patricio I Meneses "}, {"type": "b", "children": [{"type": "t", "text": "Guanine exchange factor Vav2: a novel potential target for the development of drugs effective in the prevention of papillomavirus infection and disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Ther (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MJT.0b013e31819be0a5"}], "href": "https://doi.org/10.1097/MJT.0b013e31819be0a5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19451809"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19451809"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Myung-soon Moon, Timothy M Gomez "}, {"type": "b", "children": [{"type": "t", "text": "Balanced Vav2 GEF activity regulates neurite outgrowth and branching in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Neurosci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mcn.2010.03.001"}], "href": "https://doi.org/10.1016/j.mcn.2010.03.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20298788"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20298788"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Kollu N Rao, Inderjeet Kaur, Rajul S Parikh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variations in NTF4, VAV2, and VAV3 genes are not involved with primary open-angle and primary angle-closure glaucomas in an indian population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Invest Ophthalmol Vis Sci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1167/iovs.10-5553"}], "href": "https://doi.org/10.1167/iovs.10-5553"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20463313"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20463313"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Sandra Nischwitz, Sabine Cepok, Antje Kroner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuroimmunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jneuroim.2010.06.003"}], "href": "https://doi.org/10.1016/j.jneuroim.2010.06.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20598377"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20598377"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Jan Peter Boettcher, Marieluise Kirchner, Yuri Churin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tyrosine-phosphorylated caveolin-1 blocks bacterial uptake by inducing Vav2-RhoA-mediated cytoskeletal rearrangements."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pbio.1000457"}], "href": "https://doi.org/10.1371/journal.pbio.1000457"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20808760"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20808760"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Alexander Emami-Nemini, Antje Gohla, Henning Urlaub, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The guanine nucleotide exchange factor Vav2 is a negative regulator of parathyroid hormone receptor/Gq signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.112.078824"}], "href": "https://doi.org/10.1124/mol.112.078824"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22554804"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22554804"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Bo Wu, Fengsong Wang, Jiahai Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and structural basis for a novel interaction between Vav2 and Arap3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Struct Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jsb.2012.06.011"}], "href": "https://doi.org/10.1016/j.jsb.2012.06.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22750419"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22750419"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Dong Shi, Yoshimasa Takano, Toru Nakazawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular genetic analysis of primary open-angle glaucoma, normal tension glaucoma, and developmental glaucoma for the VAV2 and VAV3 gene variants in Japanese subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2013.02.003"}], "href": "https://doi.org/10.1016/j.bbrc.2013.02.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23402756"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23402756"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Adèle Salin-Cantegrel, Masoud Shekarabi, Sarah Rasheed, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Potassium-chloride cotransporter 3 interacts with Vav2 to synchronize the cell volume decrease response with cell protrusion dynamics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0065294"}], "href": "https://doi.org/10.1371/journal.pone.0065294"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23724134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23724134"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Rajakrishnan Veluthakal, Ragadeepthi Tunduguru, Daleep Kumar Arora, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VAV2, a guanine nucleotide exchange factor for Rac1, regulates glucose-stimulated insulin secretion in pancreatic beta cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-015-3707-4"}], "href": "https://doi.org/10.1007/s00125-015-3707-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26224100"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26224100"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Shasha Liu, Xue Wu, Minru Zong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis for a novel interaction between TXNIP and Vav2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1873-3468.12110"}], "href": "https://doi.org/10.1002/1873-3468.12110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26919541"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26919541"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Carmen Ruggiero, Mabrouka Doghman-Bouguerra, Silviu Sbiera, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dosage-dependent regulation of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "VAV2"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.aal2464"}], "href": "https://doi.org/10.1126/scisignal.aal2464"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28270555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28270555"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Xizhe Li, Jiali Zhu, Yuanqi Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14014"}], "href": "https://doi.org/10.1111/cas.14014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30955235"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30955235"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "P Wang, G-Z Liu, J-F Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SNHG3 silencing suppresses the malignant development of triple-negative breast cancer cells by regulating miRNA-326/integrin α5 axis and inactivating Vav2/Rac1 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202005_21333"}], "href": "https://doi.org/10.26355/eurrev_202005_21333"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32495883"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32495883"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "L Francisco Lorenzo-Martín, Natalia Fernández-Parejo, Mauricio Menacho-Márquez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-020-18524-3"}], "href": "https://doi.org/10.1038/s41467-020-18524-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32963234"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32963234"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Weiling Liu, Chuanwang Miao, Shaosen Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Signal Transduct Target Ther (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41392-021-00735-9"}], "href": "https://doi.org/10.1038/s41392-021-00735-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34462423"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34462423"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Yushun Bai, Ji Zheng, Lei Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Potentially functional genetic variants of VAV2 and PSMA4 in the immune-activation pathway and non-small cell lung cancer survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gene Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jgm.3447"}], "href": "https://doi.org/10.1002/jgm.3447"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36039727"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36039727"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Jian Ren, Xiaoling Wu, Fei-Fei Shang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The tRNA-Cys-GCA Derived tsRNAs Suppress Tumor Progression of Gliomas via Regulating VAV2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/8708312"}], "href": "https://doi.org/10.1155/2022/8708312"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36426134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36426134"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Bo Sun, Bai Ding, Yu Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AFAP1L1 promotes gastric cancer progression by interacting with VAV2 to facilitate CDC42-mediated activation of ITGA5 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-023-03871-8"}], "href": "https://doi.org/10.1186/s12967-023-03871-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36631800"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36631800"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Yinghui Chen, Yizhuo Wu, Weiqi Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vav2 promotes ductus arteriosus anatomic closure via the remodeling of smooth muscle cells by Rac1 activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Med (Berl) (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00109-023-02377-6"}], "href": "https://doi.org/10.1007/s00109-023-02377-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37804474"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37804474"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Natalia Fernández-Parejo, L Francisco Lorenzo-Martín, Juana M García-Pedrero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-024-54808-0"}], "href": "https://doi.org/10.1038/s41598-024-54808-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38374399"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38374399"}]}]}]}
|
| Synonyms | VAV-2 |
| Proteins | VAV2_HUMAN |
| NCBI Gene ID | 7410 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
VAV2 has 10,037 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 128 datasets.
Click the + buttons to view associations for VAV2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of VAV2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of VAV2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VAV2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of VAV2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of VAV2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of VAV2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving VAV2 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of VAV2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VAV2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VAV2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of VAV2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of VAV2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of VAV2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with VAV2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with VAV2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of VAV2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of VAV2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of VAV2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of VAV2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing VAV2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with VAV2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with VAV2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with VAV2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with VAV2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with VAV2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with VAV2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of VAV2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by VAV2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with VAV2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with VAV2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with VAV2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with VAV2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with VAV2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with VAV2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at VAV2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of VAV2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of VAV2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing VAV2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with VAV2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with VAV2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of VAV2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with VAV2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing VAV2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of VAV2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of VAV2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of VAV2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of VAV2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of VAV2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of VAV2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving VAV2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving VAV2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving VAV2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing VAV2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by VAV2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by VAV2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by VAV2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of VAV2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of VAV2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of VAV2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VAV2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with VAV2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with VAV2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with VAV2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with VAV2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of VAV2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for VAV2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of VAV2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of VAV2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of VAV2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VAV2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for VAV2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with VAV2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by VAV2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for VAV2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of VAV2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of VAV2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of VAV2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate VAV2 protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving VAV2 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving VAV2 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate VAV2 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate VAV2 protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of VAV2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of VAV2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with VAV2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of VAV2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing VAV2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain VAV2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by VAV2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting VAV2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of VAV2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by VAV2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of VAV2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of VAV2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing VAV2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| PANTHER Pathways | pathways involving VAV2 protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for VAV2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of VAV2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of VAV2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving VAV2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving VAV2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with VAV2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate VAV2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving VAV2 protein from the PID Pathways dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of VAV2 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2014 | pathways involving VAV2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving VAV2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of VAV2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VAV2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at VAV2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of VAV2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of VAV2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with VAV2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of VAV2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of VAV2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of VAV2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of VAV2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of VAV2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of VAV2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of VAV2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of VAV2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of VAV2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of VAV2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of VAV2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with VAV2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with VAV2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving VAV2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving VAV2 protein from the WikiPathways Pathways 2024 dataset. | |